UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 20.

Thompson, EM; Hielscher, T; Bouffet, E; Remke, M; Luu, B; Gururangan, S; Grotzer, MA; Shalaby, T (2016). Prognostic value of medulloblastoma surgical cytoreduction after accounting for molecular subgroup. Lancet Oncology, 17(4):484-495.

Shalaby, T; Achini, F; Grotzer, M A (2016). Targeting cerebrospinal fluid for discovery of brain cancer biomarkers. Journal of cancer metastasis and treatment, 2016(2):176-187.

Fiaschetti, G; Abela, L; Nonoguchi, N; Dubuc, A M; Remke, M; Boro, A; Grunder, E; Siler, U; Ohgaki, H; Taylor, M D; Baumgartner, M; Shalaby, T; Grotzer, M A (2014). Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma. British Journal of Cancer, 110(3):636-647.

Lv, S Q; Kim, Y H; Giulio, F; Shalaby, T; Nobusawa, S; Yang, H; Zhou, Z; Grotzer, M; Ohgaki, H (2012). Genetic alterations in MicroRNAs in medulloblastomas. Brain Pathology, 22(2):230-239.

Guerreiro, A S; Fattet, S; Kulesza, D W; Atamer, A; Elsing, A N; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2011). A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Molecular Cancer Research, 9(7):925-935.

Fiaschetti, G; Castelletti, D; Zoller, S; Schramm, A; Schroeder, C; Nagaishi, M; Stearns, D; Mittelbronn, M; Eggert, A; Westermann, F; Ohgaki, H; Shalaby, T; Pruschy, M; Arcaro, A; Grotzer, M A (2011). Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma. Oncogene, 30(25):2823-2835.

Grotzer, M A; Shalaby, T; Arcaro, A (2011). Central nervous system atyypical teratoid/rhabdoid tumors: role of insulin-like factor I receptor. In: Hayat, M A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Brain Cancer. Heidelberg: Springer , 353-364.

Faoro, D; von Bueren, A O; Shalaby, T; Sciuscio, D; Hürlimann, M L; Arnold, L; Gerber, N U; Haybaeck, J; Mittelbronn, M; Rutkowski, S; Hegi, M; Grotzer, M A (2011). Expression of O(6)-methylguanine-DNA methyltransferase in childhood medulloblastoma. Journal of Neuro-Oncology, 103(1):59-69.

Grunder, E; D'Ambrosio, R; Fiaschetti, G; Abela, L; Arcaro, A; Zuzak, T; Ohgaki, H; Lv, S Q; Shalaby, T; Grotzer, M (2011). MicroRNA-21 suppression impedes medulloblastoma cell migration. European Journal of Cancer, 47(16):2479-2490.

Fiaschetti, G; Grotzer, M A; Shalaby, T; Castelletti, D; Arcaro, A (2011). Quassinoids: From traditional drugs to new cancer therapeutics. Current Medicinal Chemistry, 18(3):316-328.

Grotzer, M A; Shalaby, T (2011). Translational Investigations of Liver Tumors: Sampling Strategies and Banking. In: Zimmermann, A. Pediatric liver tumors. Berlin Heidelberg: Springer, 53-58.

von Bueren, A O; Oehler, C; Shalaby, T; von Hoff, K; Pruschy, M; Seifert, Burkhardt; Gerber, N U; Warmuth-Metz, M; Stearns, D; Eberhart, C G; Kortmann, R D; Rutkowski, S; Grotzer, M A (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer, 11:74.

Castelletti, D; Fiaschetti, G; Di Dato, V; Ziegler, U; Kumps, C; De Preter, K; Zollo, M; Speleman, F; Shalaby, T; De Martino, D; Berg, T; Eggert, A; Arcaro, A; Grotzer, M A (2010). The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors. Molecular Cancer Therapeutics, 9(12):3145-3157.

Shalaby, T; Hiyama, E; Grotzer, M A (2010). Telomere maintenance as therapeutic target in embryonal tumours. Anti-Cancer Agents in Medicinal Chemistry, 10(3):196-212.

Shalaby, T; et al; Nagasawa, K; Jelesarov, I (2010). Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD. Molecular Cancer Therapeutics, 9(1):167-169.

von Bueren, A O; Shalaby, T; Oehler-Jänne, C; Arnold, L; Stearns, D; Eberhart, C G; Arcaro, A; Pruschy, M; Grotzer, M A (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer, 9:10.

Grotzer, M A; Castelletti, D; Fiaschetti, G; Shalaby, T; Arcaro, A (2009). Targeting Myc in pediatric malignancies of the central and peripheral nervous system. Current Cancer Drug Targets, 9(2):176-188.

Guerreiro, A S; Fattet, S; Fischer, B; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2008). Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration. Clinical Cancer Research, 14(21):6761-6769.

Boller, D; Schramme, A; Doepfner, K T; Shalaby, T; von Bueren, A O; Eggert, A; Grotzer, M A; Arcaro, A (2008). Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. Clinical Cancer Research, 14(4):1172-1181.

Junge, S; Kloeckener-Gruissem, B; Zufferey, R; Keisker, A; Salgo, B; Fauchere, J C; Scherer, F; Shalaby, T; Grotzer, M; Siler, U; Seger, R; Güngör, T (2007). Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. European Journal of Immunology, 37(11):3270-3280.

This list was generated on Sat Jul 22 01:33:30 2017 CEST.